References
- Tsuyama N, Sakamoto K, Sakata S, Dobashi A, Takeuchi K. Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects. J Clin Exp Hematop 2017;57:120-42. https://doi.org/10.3960/jslrt.17023
- Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006;107:265-76. https://doi.org/10.1182/blood-2005-06-2508
- Savage KJ, Harris NL, Vose JM, Ullrich F, Jaffe ES, Connors JM, et al. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood 2008;111:5496-504. https://doi.org/10.1182/blood-2008-01-134270
- Kaseb H, Mukkamalla SKR, Rajasurya V. Anaplastic large cell lymphoma. In: StatPearls [Internet]. StatPearls Publishing; 2023. Available from: https://pubmed.ncbi.nlm.nih.gov/30725835/
- Knauss HM, Glosser LD, Beran A, Sidwell AN, Abdulsattar W, Skeel RT, et al. Anaplastic large cell lymphoma presenting as ulcerative facial mass: a case report. Case Rep Oncol 2022;15:199-206. https://doi.org/10.1159/000522267
- Luo J, Jiang YH, Lei Z, Miao YL. Anaplastic lymphoma kinasenegative anaplastic large cell lymphoma masquerading as Behcet's disease: a case report and review of literature. World J Clin Cases 2019;7:3377-83. https://doi.org/10.12998/wjcc.v7.i20.3377
- Shustov A, Cabrera ME, Civallero M, Bellei M, Ko YH, Manni M, et al. ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project. Blood Adv 2021;5:640-8. https://doi.org/10.1182/bloodadvances.2020001581
- Polyatskin IL, Artemyeva AS, Krivolapov YA. Revised WHO classification of tumors of hematopoietic and lymphoid tissues, 2017 (4th edition):lymphoid tumors. Arkhiv Patologii 2019;81:59-65. https://doi.org/10.17116/patol20198103159
- Kao EY, Mukkamalla SKR, Lynch DT. ALK negative anaplastic large cell lymphoma. In: StatPearls [Internet]. StatPearls Publishing; 2023. Available from: https://pubmed.ncbi.nlm.nih.gov/30085561/
- Hapgood G, Savage KJ. The biology and management of systemic anaplastic large cell lymphoma. Blood 2015;126:17-25. https://doi.org/10.1182/blood-2014-10-567461
- Fanale MA, Horwitz SM, Forero-Torres A, Bartlett NL, Advani RH, Pro B, et al. Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I study. J Clin Oncol 2014;32:3137-43. https://doi.org/10.1200/JCO.2013.54.2456
- Horwitz S, O'Connor OA, Pro B, Illidge T, Fanale M, Advani R, et al. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial. Lancet 2019;393:229-40. https://doi.org/10.1016/S0140-6736(18)32984-2
- Al-Rohil RN, Torres-Cabala CA, Patel A, Tetzlaff MT, Ivan D, Nagarajan P, et al. Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel finding. J Cutan Pathol 2016;43:1161-6. https://doi.org/10.1111/cup.12797
- Han SW, Kim J, Kim SW, Eom M, Yang CE. Intramuscular epidermal cyst in the masticator space: a case report. Arch Craniofac Surg 2023;24:193-7. https://doi.org/10.7181/acfs.2023.00136
- Al-Hamadani M, Habermann TM, Cerhan JR, Macon WR, Maurer MJ, Go RS. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: a longitudinal analysis of the National Cancer Data Base from 1998 to 2011. Am J Hematol 2015;90:790-5. https://doi.org/10.1002/ajh.24086
- Kim HK, Kang SH, Kim WS, Kang SH, Kim WJ, Kim HS, et al. Scalp metastasis from an adenocarcinoma of the lung mimicking a cystic mass: case report and literature review. Arch Craniofac Surg 2022;23:237-40. https://doi.org/10.7181/acfs.2022.00892